Drug details:
Molecular formula: C₁₄H₁₈BrClN₄O

Standard name: 3-(2-amino-1H-imidazol-5-yl)-N-[2-(4-bromophenyl)ethyl]propanamide;hydrochloride

Curated SMILES: C1=CC(=CC=C1CCNC(=O)CCC2=CN=C(N2)N)Br.Cl

Evidence for compound's anti-virulence activity:

Pseudomonas
Related VFcategory: Biofilm
Target: Not determined
Drug effect: Inhibits biofilm formation.
Max phase: Preclinical (in vitro)
Publication:
Ballard TE, et al., 2008. Synthesis and antibiofilm activity of a second-generation reverse-amide oroidin library: a structure-activity relationship study. Chemistry 14(34):10745-61.